We are a NY-based seed fund and day-one partner for Israeli founders building category-defining companies.
Investment Stage: Seed; Series A
Portfolio 2
| Date | Name | Website | Total Raised | Location |
| 12.08.2026 | Remepy | remepy.com | $51M | Israel |
| 13.07.2023 | Aktivate | aktivate.com | $10.7M | United Sta... |
Mentions in press and media 7
| Date | Title | Description |
| 16.08.2026 | Remepy Secures $36 Million Series A, Propelling Hybrid Drug Innovation | Remepy, a New York biotech, secured $36 million in Series A funding. Total raised hits $62 million. O.G. Venture Partners and M Ventures led the round. Funds drive Hybrid Drug development and Parkinson's program, Hybridopa, into global Phas... |
| 12.08.2026 | Remepy Raises $36M in Series A Funding | Remepy, a NYC-based provider of a platform for hybrid drugs that combine prescription medicines with personalized, AI-driven therapeutic apps, raised $36M in Series A funding. The round was led by O.G. Venture Partners and M Ventures, with ... |
| 12.08.2026 | Remepy Snares $36 Million Series A | NEW YORK, NY, Remepy, the pioneer of Hybrid Drugs, announced the closing of a $36 million Series A financing round led by O.G. Venture Partners and M Ventures. >> Click here for more funding data on Remepy >> To export Remepy f... |
| 03.08.2026 | Marquee Raises $4M in Seed Funding | Marquee, a NYC-based developer of an AI-powered decision layer for professional sports organizations, raised $4m in seed funding. The round, which brought total cumulative funding to $6.5m, was led by AnD Ventures, with participation from A... |
| 14.05.2025 | Celery Secures $6.25M to Transform Financial Oversight with AI | In the bustling world of finance, where precision is paramount, Celery has emerged as a beacon of innovation. This Tel Aviv-based startup recently secured $6.25 million in seed funding, bringing its total to $9 million. The funding round wa... |
| 13.05.2025 | Celery Secures $6.25M Automate Financial Controls with AI | What You Should Know: – Celery, a financial operations platform leveraging artificial intelligence to automate internal controls secures $6.25M in seed funding led by Team8 Capital, with participation from Verissimo Ventures, Centre Street ... |
| 10.10.2024 | 97212 Ventures: Interview With Founder Eyal Bino About The Israel-Based Venture Firm | 97212 Ventures is a seed fund exclusively focused on investing in top early stage Israeli startups committed to building category defining companies in NYC. Pulse 2.0 interviewed 97212 Ventures founder Eyal Bino to learn more about the firm... |